The goals of our program are to closely monitor various aspects of heart health in cancer patients at risk; providing state-of-the- art screening and diagnostic tests; and to begin treatment when appropriate, using the best therapies available, simultaneously allowing continuation and completion of cancer treatment which is vital for survival.

• To provide care for patients with a cardiovascular history (such as coronary artery disease, hypertension, etc) who now have to undergo cancer treatment (with agents such as anthracycline, herceptin, VEGF-inhibitors or radiation therapy).
• To provide care for patients who present with any cardiovascular symptoms, heart failure or arrhythmias following traditional treatments associated with cardiac dysfunction including anthracyclines, herceptin, and newer agents such as VEGF-inhibitors.
• Study the utility of advanced imaging techniques for detection of subclinical cancer-therapy related micro- and macrovascular disease.